Gene expression in the brain refers to the process by which information from a gene is used to synthesize functional gene products (typically proteins) in brain cells. The brain exhibits remarkably diverse gene expression patterns across different cell types, brain regions, and developmental stages. Understanding these patterns is crucial for deciphering the molecular mechanisms underlying normal brain function and neurodegenerative diseases like Alzheimer's Disease (AD) and Parkinson's Disease (PD)[@briancon].
Gene expression in the brain involves multiple steps:
- Transcription: DNA is transcribed into messenger RNA (mRNA) by RNA polymerase II
- RNA Processing: Pre-mRNA undergoes splicing, capping, and polyadenylation
- Translation: mRNA is translated into proteins by ribosomes in the cytoplasm
- Post-translational Modification: Proteins undergo modifications that affect their stability, localization, and function
The regulation of gene expression in the brain is particularly complex due to the diverse array of neuronal and glial cell types, each with distinct functional requirements[@broken2024].
The human brain shows unique gene expression signatures:
- Neuron-specific genes: Those involved in synaptic transmission, neurotransmitter synthesis, and action potential generation
- Glia-specific genes: Those encoding myelin proteins, astrocyte markers, and microglial immune response genes
- Region-specific expression: Different brain regions show distinct transcriptional profiles reflecting their specialized functions
The SEA-AD consortium and Allen Brain Atlas have mapped these patterns at unprecedented resolution[@mathys2023].
Alzheimer's disease and other neurodegenerative conditions are characterized by dysregulated gene expression. Key findings from recent research include:[@briancon][@broken2024]
- Transcriptional changes: Thousands of genes show altered expression patterns in AD brains compared to healthy controls
- Cell-type specific effects: Different neurons, microglia, astrocytes, and oligodendrocytes show distinct gene expression changes during disease progression
- Epigenetic modifications: DNA methylation and histone modifications affect gene expression in AD — the "broken AD genome" hypothesis suggests that epigenetic dysregulation is a primary driver of transcriptional dysfunction[@broken2024]
- Splicing defects: Widespread aberrant splicing in AD brain, particularly in the prefrontal cortex and hippocampus
Single-cell RNA sequencing measures gene expression at the level of individual cells, revealing cellular heterogeneity that bulk tissue analysis cannot detect[@zhao2023]. This technique has enabled:
Spatial transcriptomics preserves the spatial context of gene expression measurements, allowing researchers to understand how gene expression varies across different brain regions[@espindola2022]. This is particularly valuable for:
- Identifying spatial domains with coherent expression patterns
- Correlating gene expression with histopathological features (amyloid plaques, neurofibrillary tangles)
- Understanding the spatial organization of pathological changes relative to vulnerable brain regions
- Mapping cell-type distributions in the context of neuroanatomy
Single-nucleus RNA sequencing is particularly valuable for studying frozen or archived brain tissue, as it isolates nuclei rather than intact cells[@grynberg2022]. This approach has enabled:
- Large-scale studies of postmortem human brain tissue from well-characterized AD cohorts
- Integration with genetic data to understand variant effects on gene expression (eQTL analysis)
- Analysis of rare cell populations that are difficult to capture with scRNA-seq
- Multi-omics integration combining chromatin accessibility with gene expression[@viq2023]
The Seattle-Alzheimer's Disease Brain Cell Atlas (SEA-AD) consortium has revealed:[@mathys2023]
- Dynamic molecular mechanisms: Longitudinal gene expression data shows progressive molecular changes during neurodegeneration
- eQTL analysis: Genetic variants affecting gene expression in the brain are enriched for AD risk variants identified in GWAS
- Cell-to-cell variability: Single-cell approaches reveal extensive variability in gene expression between seemingly similar cells
- Vulnerability mapping: Certain neurons in the prefrontal cortex are particularly vulnerable to AD-related transcriptional dysregulation
Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information from GWAS studies, suggesting that splicing dysregulation is a mechanistic link between genetic risk and disease phenotypes in Parkinson's Disease and related disorders[@pimenova2024].
Single-cell data enables inference of gene regulatory networks (GRNs) that control cell-type-specific gene expression programs. These networks reveal:
- Master transcription factors driving cell identity and disease responses
- Downstream target genes that may be tractable therapeutic targets
- Network rewiring in disease states relative to healthy controls[@chan2021]
bfe67bb53c3c532ef4237fa3323691ae27404769
bfe67bb53c3c532ef4237fa3323691ae27404769